Merck and Bayer's vericiguat successful in late-stage heart failure study
Seeking Alpha,
Bayer ( OTCPK:BAYRY ) and collaboration partner Merck (NYSE: MRK ) announce positive results from a Phase 3 clinical trial trial…
Bayer ( OTCPK:BAYRY ) and collaboration partner Merck (NYSE: MRK ) announce positive results from a Phase 3 clinical trial trial…
The first patient has been enrolled in a pivotal Phase 3 clinical trial,VICTORIA, assessing Bayer's ( OTCPK:BAYRY ) vericiguat…